My top-up yesterday was the second within a few days. Whether it's U or V or any other shape this still looks to be a great long-term bet: and as with 'Sage', I too have invested on behalf of the next generation.
The recent sp rise has forced me to consider rebalancing my portfolio. Having already, earlier this year, revised my rule-of-thumb and raised the limit for any single investment [from 15% to 20% of portfolio], the choice was to either off-load some GROW shares or to raise that limit again. Limit raised!
I've seen much optimism on this board based on the belief that AffiDX offers the best lateral flow test. But *who* is it that says it is the best? I'm unconvinced at this stage because if it was the best surely AVACTA would be making commercial strides.
RE: New to investing, any tips on taking position?17 Jun 2021 10:41
With tongue in cheek, a word of warning to ORuin. " ... would like some money put away for the future": it becomes hard to *sell* an investment as successful as Draper Esprit [says one who to date has made, I think, 18 separate purchases and zero sells].
With sp boost this morning we shareholders should be smiling. Time perhaps to ask: could someone explain please the difference in the terms "ordinary" and "automatic" seen in the table of recent trades. Thanks!
This certainly is a lively BB. My first AVCT post [07.01 today], expressing disappointment with the lack of commercial information within yesterday’s webinar, and I take stick. Should a “one horse post” go into the filter book? Every journey starts with a single step. Is my nervousness reflected in the MM’s since the webinar? Without a doubt! As for “F ing off” with my imaginary shares; and will I “jog right on”? No, not yet, my investment(s) which are real need direction and these BBs help (even if not all of the postings are useful). But to the many posters sticking to the facts, thanks, and good luck!
I was impressed by the science; very impressed. But there was very little to excite on the commercial front and it's the commerce, not the science, which will determine where the share price goes. So in my eyes this was another missed opportunity. AS is no fool so one has to ask why: it makes me nervous!